Amyotrophic Lateral Sclerosis (ALS) - Related Resources

Cochrane reviews

Recombinant human insulin-like growth factor I may slow disease progression in amyotrophic lateral sclerosis/motor neuron disease but the evidence is very limited and the clinical significance of the effect is uncertain Recombinant Human Insulin-Like Growth Factor I for Amyotrophic Lateral Sclerosis/Motor Neuron Disease.
The evidence is insufficient to determine whether individualized moderate intensity endurance type exercises for the trunk and limbs are beneficial or harmful for spasticity in motor neuron disease Treatment for Spasticity in Amyotrophic Lateral Sclerosis/Motor Neuron Disease.
There is insufficient evidence of efficacy of individual antioxidants, or antioxidants in general, in the treatment of people with amyotrophic lateral sclerosis Antioxidant Treatment for Amyotrophic Lateral Sclerosis.
Strengthening exercises may improve function in people with amyotrophic lateral sclerosis Therapeutic Exercise for Amyotrophic Lateral Sclerosis (ALS).
The treatment response in patients with familial and sporadic forms of ALS seems not to be different, but the evidence is insufficient Treatment for Familial Amyotrophic Lateral Sclerosis.
Creatine appears not to improve survival or slow progression in amyotrophic lateral sclerosis Creatine for Amyotrophic Lateral Sclerosis.
There is no evidence to support the use of any treatment for muscle cramps in ALS Treatment for Cramps in Amyotrophic Lateral Sclerosis.
Ciliary neurotrophic factor (CNTF) appears not to be effective for amyotrophic lateral sclerosis Ciliary Neurotrophic Factor (Cntf) for Amyotrophic Lateral Sclerosis/Motor Neuron Disease.

OtherInternet resources

Amyotrophic lateral sclerosis.Orphanet ORPHA803 http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=106&Disease_Disease_Search_diseaseGroup=Amyotrophic-lateral-sclerosis&Disease_Disease_Search_diseaseType=Pat&Disease(s) concerned=Amyotrophic-lateral-sclerosis&title=Amyotrophic-lateral

Literature

Andersen PM, Borasio GD, Dengler R et al; EALSC Working Group. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 2007 Aug;8(4):195-213. [PubMed]
Andrews J. Amyotrophic lateral sclerosis: clinical management and research update. Curr Neurol Neurosci Rep 2009 Jan;9(1):59-68. [PubMed]

Primary/Secondary Keywords

Related resources

section name header

References

Amyotrophic Lateral Sclerosis (ALS) - Related Resources

Cochrane reviews

OtherInternet resources

Literature